Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab is a paper indexed in PICO Portal from OpenAlex.
How many citations does Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab have?
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab has 136 citations in the OpenAlex counts PICO Portal stores.
When was Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab published?
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab has 2019 year in the PICO Portal index.
What is the open-access status of Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab?
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab has gold oa status in the PICO Portal index.
What is the DOI of Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab?
The DOI for Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab is on the source record.
What is the PMID of Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab?
The PMID for Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab is on the source record.
What is the OpenAlex record for Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab?
The OpenAlex for Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab is on the source record.